Look for:

Our offer for

INCYTE CORP


ISIN:
US45337C1027
WKN:
45337C102

2019/11/20 18:20:17
Price
89.30 USD
Difference 1.55% (1.36)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,930 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)89.30 USD (200)
Ask (Ask size)89.35 USD (200)
Open87.73 USD
High90.00 USD
Low87.22 USD
Close (prev. day)87.94 USD
VWAP89.382382 USD
Volume (pcs)608,237
Trading volume54,362,030.66
Number of trades6,698
Last size100

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: INCYTE CORPPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2019/11/20 18:20:17
Price
89.30 USD
Difference 1.55% (1.36)

General attributes

ISINUS45337C1027
SymbolINCY
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,930 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)89.30 USD (200)
Ask (Ask size)89.35 USD (200)
Open87.73 USD
High90.00 USD
Low87.22 USD
Close (prev. day)87.94 USD
VWAP89.382382 USD
Volume (pcs)608,237
Trading volume54,362,030.66
Number of trades6,698
Last size100

Performance and Risk

6m1Y3Y
Perf (%)+13.91%+36.87%-15.14%
Perf (abs.)+10.74+23.69-15.69
Beta0.780.941.19
Volatility30.8733.2838.78
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)87.07 USD (1,126,682)
Ø price 30 days | Ø volume 30 days (pcs.)81.56 USD (940,714)
Ø price 100 days | Ø volume 100 days (pcs.)80.66 USD (1,079,671)
Ø price 250 days | Ø volume 250 days (pcs.)79.04 USD (1,292,278)
YTD High | date89.30 USD (2019/06/24)
YTD Low | date62.03 USD (2019/01/02)
52 Weeks High | date89.30 USD (2019/06/24)
52 Weeks Low | date57.00 USD (2018/12/24)

All listings for INCYTE CORP

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2019/11/2017:3280.76 EUR0.002
Tradegate2019/11/2017:4781.28 EUR0.1124
Stuttgart2019/11/2017:1880.98 EUR0.0110
Nasdaq2019/11/2018:2089.30 USD54.366,698
Munich2019/11/2017:5681.20 EUR0.008
London Stock Exchange2019/08/1921:3784.7300 USD0.001
Frankfurt2019/11/2015:5179.92 EUR0.113
Duesseldorf2019/11/2013:1779.25 EUR0.004
Berlin2019/11/2017:4281.14 EUR0.0011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=130964&ID_TYPE_IMAGE_LOGO=2

Contact Details

INCYTE CORPORATION
Michael Booth
Augustine Cut-Off 1801 19803 Wilmington, DE
Telefon: +1-302-498-6700
Fax: -
E-mail: mbooth@incyte.com

PDF Downloads

Company report: INCYTE CORPPDF Download

Company Profile

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.

Members of Management Board

Hervé HoppenotChairman of Board of Directors
Paul J. ClancyMember of Board of Directors
Paul A. Friedman, M.D.Member of Board of Directors
Paul A. BrookeMember of Board of Directors
Julian C. BakerMember of Board of Directors
Jean-Jacques BienaiméMember of Board of Directors
Wendy DixonMember of Board of Directors
Jacqualyn A. FouseMember of Board of Directors
Hervé HoppenotChairman of Managing Board
Vijay Iyengar, M.D.Member of Executive Committee
Steven H. Stein, M.D.Member of Executive Committee
Paula J. SwainMember of Executive Committee
Michael MorrisseyMember of Executive Committee
Maria E. PasqualeMember of Executive Committee
Jonathan E. DickinsonMember of Executive Committee
Dash DhanakMember of Executive Committee
Christiana StamoulisMember of Executive Committee
Barry P. FlannellyMember of Executive Committee
Wenqing YaoMember of Executive Committee
Lothar H. FinkeMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer